ATHENS – African nations led by Somalia, Mauritania and Sudan have the most precarious water supplies in the world while Iceland has the best, according to a survey on Thursday that aims to alert companies to investment risks. The ranking, compiled by British-based risk consultancy Maplecroft, said climate change and a rising world population meant that stresses on supplies would be of inc
LOS ANGELES (Reuters) Bristol-Myers Squibb Co will pay another $17 million to end its development collaboration for Exelixis Inc's experimental cancer drug XL184.Exelixis said on Sunday it will continue to develop the drug, which is being studied as a treatment for thyroid cancer, glioblastoma and other solid tumors. We have the resources to take this forward for some time, Exelixis Chief Execu
CHICAGO (Reuters) Abraxis Bioscience Inc said its cancer drug Abraxane outperformed the generic drug Taxol in patients with non-small cell lung cancer, without requiring patients to take steroids or antihistamines, U.S researchers said on Saturday.They said 33 percent of patients who got Abraxane in combination with the chemotherapy drug carboplatin responded to it, compared with 25 percent of
LONDON – Officials urged Bristol-Myers Squibb not to shut down a plant in France which makes AIDS drugs, saying the move will jeopardize the lives of thousands of babies.In a letter published in the journal Lancet on Monday, officials at UNITAID, which buys drugs for AIDS, Oxfam and others said they were deeply concerned that Bristol-Myers Squibb Co.is planning to close a French factory tha
CHICAGO (Reuters) When your hair turns white it is usually a sign of old age, but in advanced melanoma patients taking a new type of cancer treatment, it may be a very good sign, researchers said on Saturday.They said Bristol-Myers Squibb's ipilimumab and Pfizer's tremelimumab two experimental drugs that aim to fight cancer by boosting the immune system had the peculiar effect of turning some
CHICAGO (Reuters) When your hair turns white it is usually a sign of old age, but in advanced melanoma patients taking a new type of cancer treatment, it may be a very good sign, researchers said on Saturday.They said Bristol-Myers Squibb's ipilimumab and Pfizer's tremelimumab two experimental drugs that aim to fight cancer by boosting the immune system had the peculiar effect of turning some
CHICAGO Researchers have scored the first big win against melanoma, the deadliest form of skin cancer.An experimental drug significantly improved survival in a major study of people with very advanced disease.The results, reported Saturday at a cancer conference, left doctors elated. We have not had any therapy that has prolonged survival until now, said Dr.Lynn Schuchter of the Abramson Cancer